Works matching IS 00071048 AND DT 2017 AND VI 177 AND IP 2

Results: 24
    1
    2
    3
    4

    Editor's note.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 331, doi. 10.1111/bjh.14674
    Publication type:
    Article
    5
    6
    7
    8
    9
    10

    Issue Information.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 159, doi. 10.1111/bjh.14355
    Publication type:
    Article
    11

    Marizomib for central nervous system-multiple myeloma.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 221, doi. 10.1111/bjh.14498
    By:
    • Badros, Ashraf;
    • Singh, Zeba;
    • Dhakal, Binod;
    • Kwok, Young;
    • MacLaren, Ann;
    • Richardson, Paul;
    • Trikha, Mohit;
    • Hari, Parameswaran
    Publication type:
    Article
    12

    The evolving indications for splenectomy.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 321, doi. 10.1111/bjh.14060
    By:
    • Browning, Matthew G;
    • Bullen, Naomi;
    • Nokes, Tim;
    • Tucker, Keri;
    • Coleman, Mark
    Publication type:
    Article
    13
    14
    15

    High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R- FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 263, doi. 10.1111/bjh.14541
    By:
    • Nastoupil, Loretta J.;
    • McLaughlin, Peter;
    • Feng, Lei;
    • Neelapu, Sattva S.;
    • Samaniego, Felipe;
    • Hagemeister, Fredrick B.;
    • Ayala, Ana;
    • Romaguera, Jorge E.;
    • Goy, Andre H.;
    • Neal, Eleanor;
    • Wang, Michael;
    • Fayad, Luis;
    • Fanale, Michelle A.;
    • Oki, Yasuhiro;
    • Westin, Jason R.;
    • Rodriguez, Maria A.;
    • Cabanillas, Fernando;
    • Fowler, Nathan H.
    Publication type:
    Article
    16
    17
    18
    19
    20

    Using electronic medical record data to report laboratory adverse events.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 283, doi. 10.1111/bjh.14538
    By:
    • Miller, Tamara P.;
    • Li, Yimei;
    • Getz, Kelly D.;
    • Dudley, Jesse;
    • Burrows, Evanette;
    • Pennington, Jeffrey;
    • Ibrahimova, Azada;
    • Fisher, Brian T.;
    • Bagatell, Rochelle;
    • Seif, Alix E.;
    • Grundmeier, Robert;
    • Aplenc, Richard
    Publication type:
    Article
    21
    22

    A phase 1/2 trial of ublituximab, a novel anti- CD20 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 243, doi. 10.1111/bjh.14534
    By:
    • Sawas, Ahmed;
    • Farber, Charles M.;
    • Schreeder, Marshall T.;
    • Khalil, Mazen Y.;
    • Mahadevan, Daruka;
    • Deng, Changchun;
    • Amengual, Jennifer E.;
    • Nikolinakos, Petros G.;
    • Kolesar, Jill M.;
    • Kuhn, John G.;
    • Sportelli, Peter;
    • Miskin, Hari P.;
    • O'Connor, Owen A.
    Publication type:
    Article
    23
    24

    The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.

    Published in:
    British Journal of Haematology, 2017, v. 177, n. 2, p. 287, doi. 10.1111/bjh.14537
    By:
    • Alfred, Arun;
    • Taylor, Peter C.;
    • Dignan, Fiona;
    • El ‐ Ghariani, Khaled;
    • Griffin, James;
    • Gennery, Andrew R.;
    • Bonney, Denise;
    • Das ‐ Gupta, Emma;
    • Lawson, Sarah;
    • Malladi, Ram K.;
    • Douglas, Kenneth W.;
    • Maher, Tracey;
    • Guest, Julie;
    • Hartlett, Laura;
    • Fisher, Andrew J.;
    • Child, Fiona;
    • Scarisbrick, Julia J.
    Publication type:
    Article